MedPath

Somatostatin receptor scintigraphy in patients with multiple myeloma or plasmocytoma

Conditions
Multiple myeloma
plasmacytoma
10035227
10018865
Registration Number
NL-OMON30229
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
45
Inclusion Criteria

-Upfront patients with MM that are treated according to the HOVON-49 or HOVON-65 protocol.
-Upfront patients with plasmacytoma.
-Relapsed MM patients with painful affected areas.

Exclusion Criteria

-Radiotherapy lasting longer than 5 days ago in the last 3 months.
-Ineligible to perform a scan.
-Age under 18 years.
-Pregnancy
-Severe kidney-dysfunction

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath